Literature DB >> 12009018

Prostaglandin E2 induces interaction between hSlo potassium channel and Syk tyrosine kinase in osteosarcoma cells.

Roger Rezzonico1, Annie Schmid-Alliana, Georges Romey, Isabelle Bourget-Ponzio, Véronique Breuil, Violette Breittmayer, Sophie Tartare-Deckert, Bernard Rossi, Heidy Schmid-Antomarchi.   

Abstract

Prostaglandins (PGs) are important mediators of bone response to growth factors, hormones, inflammation, or mechanical strains. In this study, we show that in MG63 osteosarcoma cells, prostaglandin E2 (PGE2) produces the opening of a large conductance Ca2+-dependent K+ channel (BK). This PGE2-mediated channel opening induces the recruitment of various tyrosine-phosphorylated proteins on the hSlo alpha-subunit of BK. Because the C-terminal domain of hSlo encompasses an immunoreceptor tyrosine-based activation motif (ITAM), we show that the Syk nonreceptor tyrosine kinase, reported yet to be expressed mainly in hematopoietic cells, is expressed also in osteoblastic cells, and recruited on this ITAM after a PGE2-induced docking/activation process. We show that Syk/hSlo association is dependent of an upstream Src-related tyrosine kinase activity, in accord with the classical two-step model described for immune receptors. Finally, we provide evidence that this Syk/hSlo interaction does not affect the electrical features of BK channels in osteosarcoma cells. With these data, we would like to suggest the new notion that besides its conductance function, hSlo channel can behave in bone cells, as a true transduction protein intervening in the bone remodeling induced by PGE2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009018     DOI: 10.1359/jbmr.2002.17.5.869

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  15 in total

Review 1.  MaxiK channel partners: physiological impact.

Authors:  Rong Lu; Abderrahmane Alioua; Yogesh Kumar; Mansoureh Eghbali; Enrico Stefani; Ligia Toro
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

2.  Identification and functional characterization of ankyrin-repeat family protein ANKRA as a protein interacting with BKCa channel.

Authors:  Hyun-Ho Lim; Chul-Seung Park
Journal:  Mol Biol Cell       Date:  2004-12-22       Impact factor: 4.138

3.  KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis.

Authors:  Mark R Tanner; Xueyou Hu; Redwan Huq; Rajeev B Tajhya; Liang Sun; Fatima S Khan; Teresina Laragione; Frank T Horrigan; Pércio S Gulko; Christine Beeton
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

Review 4.  MaxiK channel and cell signalling.

Authors:  Ligia Toro; Min Li; Zhu Zhang; Harpreet Singh; Yong Wu; Enrico Stefani
Journal:  Pflugers Arch       Date:  2014-05       Impact factor: 3.657

5.  Modulation of glioma BK channels via erbB2.

Authors:  M L Olsen; A K Weaver; P S Ritch; H Sontheimer
Journal:  J Neurosci Res       Date:  2005-07-15       Impact factor: 4.164

6.  A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts.

Authors:  Neil C Henney; Bo Li; Carole Elford; Pablo Reviriego; Anthony K Campbell; Kenneth T Wann; Bronwen A J Evans
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-23       Impact factor: 4.249

7.  Alpha5beta1 integrin engagement increases large conductance, Ca2+-activated K+ channel current and Ca2+ sensitivity through c-src-mediated channel phosphorylation.

Authors:  Yan Yang; Xin Wu; Peichun Gui; Jianbo Wu; Jian-Zhong Sheng; Shizhang Ling; Andrew P Braun; George E Davis; Michael J Davis
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

8.  Association of beta-catenin with the alpha-subunit of neuronal large-conductance Ca2+-activated K+ channels.

Authors:  F Lesage; H Hibino; A J Hudspeth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-30       Impact factor: 11.205

9.  Antagonism of chemokine receptor CXCR3 inhibits osteosarcoma metastasis to lungs.

Authors:  Emmanuelle Pradelli; Babou Karimdjee-Soilihi; Jean-François Michiels; Jean-Ehrland Ricci; Marie-Ange Millet; Fanny Vandenbos; Timothy J Sullivan; Tassie L Collins; Michael G Johnson; Julio C Medina; Eugenie S Kleinerman; Annie Schmid-Alliana; Heidy Schmid-Antomarchi
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

10.  Osteosarcoma Phenotype Is Inhibited by 3,4-Methylenedioxy-β-nitrostyrene.

Authors:  Patrick J Messerschmitt; Ashley N Rettew; Nicholas O Schroeder; Robert E Brookover; Avanti P Jakatdar; Patrick J Getty; Edward M Greenfield
Journal:  Sarcoma       Date:  2012-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.